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Predictors of Problematic Non-Medical Prescription Pain and Stimulant Use
Tess K. Drazdowski, M.S. & Wendy L. Kliewer, Ph.D.
Department of Psychology and Clark-Hill Institute for Positive Youth Development, Virginia Commonwealth University

BACKGROUND

METHODS

Recent results from a nationally representative sample
indicated that young adults exhibited the greatest illicit drug use
(SAMHSA, 2013b). The non-medical use of prescription drugs
(NMUPD) is the second most commonly reported form of illicit
substance use by young adults, preceded only by marijuana
(SAMHSA, 2013b). This is a growing public health concern with
an estimated 2.4 million Americans engaging in NUMPD for the
first time within the past year in 2010, an average of 6,600
initiates per day (SAMHSA, 2013b). Prescription opioid abuse
alone was estimated to cost the U.S. $55.7 billion in 2007
(Birnbaum et al., 2011). NMUPD has been linked with abuse and
dependence, and a variety of other negative outcomes, including
mental illness (e.g., Bavarian et al., 2013), poor school
performance (Arria et al., 2011), emergency room visits
(SAMHSA, 2013a, 2013b), more frequent sexual risk behaviors
(Benotsch et al., 2011), and death (CDC, 2012; Paulozzi et al.,
2012). Additionally, young adults who engage in NMUPD are
significantly more likely than their peers to use other illicit drugs
and to combine prescription drugs with alcohol and other
substances. These practices increase the risk of potentially
dangerous drug interactions, and their negative outcomes
(Garnier et al., 2009; McCabe et al., 2006; SAMHSA, 2006).
Therefore, prevention is key to reducing this great public health
concern and its grave costs to society. One way to prevent
substance use and abuse is to investigate why specific groups of
people use and to target interventions specifically to modifiable
predictors. The current study focuses on such potential predictors.

Measures
Participants completed an online questionnaires and received research
credit for an Introduction to Psychology class as compensation. For the
current study these included:
 Reduce Annoyed Guilty Start test (RAGS; Sobell et al., 1999): The 32-item
RAGS self-report scale was modified to examine four aspects of problem
NMUPD usage: need to stop or reduce behavior, annoyance from others
criticizing the behavior, guilt about the behavior, and needing the behavior
to start the day. This version asked these questions in terms of prescription
opioids and stimulants. Higher scores indicated greater problem usage.
 Pittsburgh Sleep Quality Index (PSQI; Buysse et al., 1989): The 19-item
self-report scale measures seven components of sleep over the past
month: sleep quality, sleep latency, duration of sleep, sleep efficiency,
disturbances of sleep, use of sleep medication, and daytime dysfunction.
Higher global PSQI scores indicated worse sleep problems or worsened
quality of sleep.
 Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004):
The 36-item self-report scale assessed emotion regulation in four domains:
awareness and understanding of one’s emotions, acceptance of emotions,
ability to engage in goal directed behavior and abstain from impulsive
behavior when faced with negative emotions, and whether one’s access to
emotion regulation strategies seemed effective. Higher scores indicated
greater difficulties in emotion regulation.
 Center for Epidemiological Studies Depression Scale (CES-D; Radloff,
1991): The 20-item self-report scale has participants rate the frequency of
which each of the statements was true for them in the past week. Higher
scores indicated greater frequency and severity of depressive symptoms.
 The Impact of Event Scale (IES; Horowitz et al., 1979): The 15-item selfreport measure assesses participants after experiencing a traumatic event.
The scale asks participants to rate to what extent each of the items are true
for them in the previous seven days. Higher scores indicate greater
problems and more PTSD symptoms.

AIMS OF CURRENT STUDY
 To determine the predictors of problematic non-medical use of
prescription stimulants and opioids in an undergraduate sample of
young adults.

METHODS
Participants
 193 undergraduate students attending a large public university
 70.4% female; 55% White
 Endorsed NMUPD of either pain or stimulant medications in the
past year
Design
 First, regressions were conducted to test whether sleep
problems, emotion regulation difficulties, depressive symptoms,
and post-traumatic stress disorder (PTSD) symptoms predicted
problematic non-medical use of either prescription stimulants or
opioids.
 Then, the significant predictors from the previous regression
models were entered into two separate multiple regression
models, one for problematic stimulant misuse and another for
problematic opioid misuse to determine which predictor was the
most influential.

RESULTS
 Using regression models run separately for users of pain and stimulant
medications, emotion regulation difficulties and PTSD symptoms were found to
predict non-medical problematic use of both pain and stimulant medication.
 Sleep problems and depressive symptoms were found to only predict problematic
use of stimulants.
 When all the significant predictors were entered into a multiple regression for
each prescription category, no one predictor was significant above and beyond other
predictors (see Table 1).
 However, PTSD symptoms explained the most variance in both models.
Table 1
Multiple Regression Analysis Examining Associations Among Significant
Correlates and Problematic Non-medical Use of Pain and Stimulant Medications
(N = 193)
Prescription Drug
Category
Pain

Stimulant

B

SE B

Β

p

DERS

0.01

0.01

.19

.19

IES

0.02

0.01

.21

.09

R2

.09

DERS

.00

.01

.05

.79

IES
PSQI

.01
.05

.01
.06

.19
.14

.22
.37

CES-D

.02

.02

.14

.50

R2

.17

Predictor

Note. DERS = Difficulties in Emotion Regulation Scale, IES = Impact of Events Scale,
PSQI = Pittsburgh Sleep Quality Index, CES-D = Center for Epidemiological Studies –
Depression Scale.

DISCUSSION
 These results suggest that all of these predictors are important to consider
when investigating NMUPD in young adults.
Limitations
 All data collected was through self-report measures which are subject to
participants responding in a socially desirable context.
 The characteristics of this population (undergraduate students at one
university) need to be considered with regards to the generalizability of these
results.
 Since results from treatment research investigating abuse of other
substances have found that integrated approaches that combine mental
health and substance use are more effective than interventions that address
substance use and mental health problems separately (e.g., Drake et al.,
2008), future prevention and intervention efforts should consider all of the
variables investigated.
 If resources are limited targeting PTSD symptoms may be the most
effective.
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